PlainRecalls
FDA Devices Moderate Class II Ongoing

The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determine susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed.

Reported: April 29, 2020 Initiated: March 11, 2020 #Z-1742-2020

Product Description

The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determine susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed.

Reason for Recall

There is a potential for the occurrence of false positive OXSF results for some Staphylococcus aureus strains in conjunction with the VITEK 2 AST-P652 test card (ref. 421857, lot 8021232403). .

Details

Recalling Firm
Biomerieux Inc
Units Affected
1698 cartons (15,940 cards)
Distribution
No distribution within the United States. Foreign distribution locations: Netherlands, Luxembourg, Belgium
Location
Hazelwood, MO

Frequently Asked Questions

What product was recalled?
The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determine susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed.. Recalled by Biomerieux Inc. Units affected: 1698 cartons (15,940 cards).
Why was this product recalled?
There is a potential for the occurrence of false positive OXSF results for some Staphylococcus aureus strains in conjunction with the VITEK 2 AST-P652 test card (ref. 421857, lot 8021232403). .
Which agency issued this recall?
This recall was issued by the FDA Devices on April 29, 2020. Severity: Moderate. Recall number: Z-1742-2020.